Clinical Trials Logo

Clinical Trial Summary

The purpose of this study was twofold: 1) to assess awareness of and adherence to Texas SB42 among a representative sample of public middle schools in Texas; and 2) to assess the impact of SB42 on the frequency of school PE class, the quality of school PE, and prevalence of child self-reported physical activity behaviors and child overweight along the Texas-Mexico border.


Clinical Trial Description

Childhood overweight is a significant public health issue in Texas. In response to this problem, the 79th Texas legislature passed Senate Bill 42 (SB 42), which promotes healthier school environments in middle schools, in June, 2005. As a result of SB 42, all Texas public middle schools must require students to engage in at least 30 minutes of daily physical activity or a total of 135 minutes of physical activity per week, beginning in the 2006-2007 school year. The purpose of this study was to determine the barriers and facilitators of implementation and the ultimate impact of this mandate on school PE, child physical activity, and child overweight in Texas public middle schools, and specifically among children living in the Lower Rio Grande Valley (LRGV) of South Texas. Questionnaires with key informants (school principals, PE teachers, and school district PE and health education directors) were conducted in a random sample of middle schools to assess the implementation of SB 42 (2006-2007). In addition, a more detailed evaluation of SB 42 was accomplished with a representative sample of middle schools in the LRGV, a low-income Latino area of the state. Measurements in the LRGV schools included observed and measured child physical activity, self-reported physical activity behaviors, and child overweight (BMI). ;


Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00672815
Study type Observational
Source The University of Texas Health Science Center, Houston
Contact
Status Completed
Phase N/A
Start date April 2006
Completion date June 2008

See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2